Prominent players in the market cited maturing validity data and updated guidelines that have led to growing awareness among doctors and patients.
Genomic Classifier for Kidney Cancer Recurrence Risk May Help Personalize Adjuvant Therapy
Sequencing of 12 cancer-related genes in clear-cell renal cell carcinoma samples identified combinations of somatic mutations that were linked to recurrence risk.
Study Unearths Features Found in Long-Term Survivors of Advanced Ovarian Cancer
Researchers examined genetic, tumor mutation, and immune features among individuals surviving at least a decade after an advanced ovarian cancer diagnosis.
The company hopes that it can persuade urology practices to go with its suite of assays by covering a fuller range of treatment decision points.
Oncocyte Nets $3M VA Contract for DetermaRx Lung Cancer Prognostic Test
The test will be covered by the VA for five years to determine the risk of recurrence in early-stage lung cancer patients after surgery.